✦ LIBER ✦

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms

✍ Scribed by Norman R. Zinner; Roger R. Dmochowski; David R. Staskin; Paul F. Siami; Peter K. Sand; Michael G. Oefelein

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 102 KB
Volume: 30
Category: Article
ISSN: 0733-2467
DOI: 10.1002/nau.21000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-daily administration of trospium ch

Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: An integrated analysis of two phase III trials

✍ David A. Ginsberg; Michael G. Oefelein; Pamela I. Ellsworth 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Obesity is associated with a more severe

Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release

✍ Michael B. Chancellor; Michael G. Oefelein; Sandip Vasavada 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

## Abstract ## Aims Obesity is an established risk factor for urinary incontinence, yet no information exists as to the efficacy of antimuscarinic agents in this population. The goal of this study is to examine the efficacy of once daily trospium chloride (Sanctura™) XR in overweight and obese pat